OBJECTIVE: We have previously identified a single-nucleotide polymorphism (SNP) haplotype involving the lymphotoxin alpha (LTA) and tumor necrosis factor (TNF) loci (termed haplotype LTA-TNF2) on chromosome 6 that shows differential association with rheumatoid arthritis (RA) on HLA-DRB1*0404 and *0401 haplotypes, suggesting the presence of additional non-HLA-DRB1 RA susceptibility genes on these haplotypes. To refine this association, we performed a case-control association study using both SNPs and microsatellite markers in haplotypes matched either for HLA-DRB1*0404 or for HLA-DRB1*0401. METHODS: Fourteen SNPs lying between HLA-DRB1 and LTA were genotyped in 87 DRB1*04-positive families. High-density microsatellite typing was performed using 24 markers spanning 2,500 kb centered around the TNF gene in 305 DRB1*0401 or *0404 cases and 400 DRB1*0401 or *0404 controls. Single-marker, 2-marker, and 3-marker minihaplotypes were constructed and their frequencies compared between the DRB1*0401 and DRB1*0404 matched case and control haplotypes. RESULTS: Marked preservation of major histocompatibility complex haplotypes was seen, with chromosomes carrying LTA-TNF2 and either DRB1*0401 or DRB1*0404 both carrying an identical SNP haplotype across the 1-Mb region between TNF and HLA-DRB1. Using microsatellite markers, we observed two 3-marker minihaplotypes that were significantly overrepresented in the DRB1*0404 case haplotypes (P = 0.00024 and P = 0.00097). CONCLUSION: The presence of a single extended SNP haplotype between LTA-TNF2 and both DRB1*0401 and DRB1*0404 is evidence against this region harboring the genetic effects in linkage disequilibrium with LTA-TNF2. Two RA-associated haplotypes on the background of DRB1*0404 were identified in a 126-kb region surrounding and centromeric to the TNF locus.
OBJECTIVE: We have previously identified a single-nucleotide polymorphism (SNP) haplotype involving the lymphotoxin alpha (LTA) and tumor necrosis factor (TNF) loci (termed haplotype LTA-TNF2) on chromosome 6 that shows differential association with rheumatoid arthritis (RA) on HLA-DRB1*0404 and *0401 haplotypes, suggesting the presence of additional non-HLA-DRB1 RA susceptibility genes on these haplotypes. To refine this association, we performed a case-control association study using both SNPs and microsatellite markers in haplotypes matched either for HLA-DRB1*0404 or for HLA-DRB1*0401. METHODS: Fourteen SNPs lying between HLA-DRB1 and LTA were genotyped in 87 DRB1*04-positive families. High-density microsatellite typing was performed using 24 markers spanning 2,500 kb centered around the TNF gene in 305 DRB1*0401 or *0404 cases and 400 DRB1*0401 or *0404 controls. Single-marker, 2-marker, and 3-marker minihaplotypes were constructed and their frequencies compared between the DRB1*0401 and DRB1*0404 matched case and control haplotypes. RESULTS: Marked preservation of major histocompatibility complex haplotypes was seen, with chromosomes carrying LTA-TNF2 and either DRB1*0401 or DRB1*0404 both carrying an identical SNP haplotype across the 1-Mb region between TNF and HLA-DRB1. Using microsatellite markers, we observed two 3-marker minihaplotypes that were significantly overrepresented in the DRB1*0404 case haplotypes (P = 0.00024 and P = 0.00097). CONCLUSION: The presence of a single extended SNP haplotype between LTA-TNF2 and both DRB1*0401 and DRB1*0404 is evidence against this region harboring the genetic effects in linkage disequilibrium with LTA-TNF2. Two RA-associated haplotypes on the background of DRB1*0404 were identified in a 126-kb region surrounding and centromeric to the TNF locus.
Authors: K A Elisa Kallio; Marja Marchesani; Efthymia Vlachopoulou; Päivi Mäntylä; Susanna Paju; Kåre Buhlin; Anna L Suominen; Johanna Contreras; Matti Knuuttila; Marcela Hernandez; Sisko Huumonen; Markku S Nieminen; Markus Perola; Juha Sinisalo; Marja-Liisa Lokki; Pirkko J Pussinen Journal: Infect Immun Date: 2014-02-24 Impact factor: 3.441
Authors: A M Abdou; X Gao; W Cozen; J R Cerhan; N Rothman; M P Martin; S Davis; M Schenk; S J Chanock; P Hartge; M Carrington; S S Wang Journal: Leukemia Date: 2010-02-11 Impact factor: 11.528
Authors: Anthony C Y Yau; Jonatan Tuncel; Sabrina Haag; Ulrika Norin; Miranda Houtman; Leonid Padyukov; Rikard Holmdahl Journal: Proc Natl Acad Sci U S A Date: 2016-06-14 Impact factor: 11.205
Authors: Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel L Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux Journal: Am J Hum Genet Date: 2005-11-01 Impact factor: 11.025
Authors: Christine F Skibola; Paige M Bracci; Alexandra Nieters; Angela Brooks-Wilson; Silvia de Sanjosé; Ann Maree Hughes; James R Cerhan; Danica R Skibola; Mark Purdue; Eleanor Kane; Qing Lan; Lenka Foretova; Maryjean Schenk; John J Spinelli; Susan L Slager; Anneclaire J De Roos; Martyn T Smith; Eve Roman; Wendy Cozen; Paolo Boffetta; Anne Kricker; Tongzhang Zheng; Tracy Lightfoot; Pierluigi Cocco; Yolanda Benavente; Yawei Zhang; Patricia Hartge; Martha S Linet; Nikolaus Becker; Paul Brennan; Luoping Zhang; Bruce Armstrong; Alex Smith; Renee Shiao; Anne J Novak; Marc Maynadie; Stephen J Chanock; Anthony Staines; Theodore R Holford; Elizabeth A Holly; Nathaniel Rothman; Sophia S Wang Journal: Am J Epidemiol Date: 2010-01-04 Impact factor: 4.897
Authors: Hye-Soon Lee; Annette T Lee; Lindsey A Criswell; Michael F Seldin; Christopher I Amos; John P Carulli; Cristina Navarrete; Elaine F Remmers; Daniel L Kastner; Robert M Plenge; Wentian Li; Peter K Gregersen Journal: Mol Med Date: 2008 May-Jun Impact factor: 6.354
Authors: S J Dunstan; K A Rockett; N T N Quyen; Y Y Teo; C Q Thai; N T Hang; A Jeffreys; T G Clark; K S Small; C P Simmons; N Day; S E O'Riordan; D P Kwiatkowski; J Farrar; N H Phu; T T Hien Journal: Genes Immun Date: 2012-06-07 Impact factor: 2.676
Authors: Holger Kirsten; Elisabeth Petit-Teixeira; Markus Scholz; Dirk Hasenclever; Helene Hantmann; Dirk Heider; Ulf Wagner; Ulrich Sack; Vitor Hugo Teixeira; Bernard Prum; Jana Burkhardt; Céline Pierlot; Frank Emmrich; François Cornelis; Peter Ahnert Journal: Arthritis Res Ther Date: 2009-05-01 Impact factor: 5.156